| HepG2 | 
Caption: IP-Western Blot analysis of HepG2 whole cell lysate using IGF2BP3 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-IGF2BP3 antibody (lanes under 'IGF2BP3'). Method: immunoprecipitation Releated Sample: eCLIP:211 Status: Released Lab: Yeo Lab | 
Caption: Western blot following shRNA against IGF2BP3 in K562 and HepG2 whole cell lysate using IGF2BP3 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against IGF2BP3. Lanes follow the same pattern, but in HepG2. IGF2BP3 protein appears as the green band, Tubulin serves as a control and appears in red. Releated Sample: BGKLV11-19 Status: Released Lab: Graveley Lab |
|---|
| K562 | 
Caption: IP-Western Blot analysis of K562 whole cell lysate using IGF2BP3 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lanes 4 and 5 are 10% IP enrichments of biological replicates using rabbit polyclonal anti-IGF2BP3 antibody (lanes under 'IGF2BP3'). Method: immunoprecipitation Status: Released Lab: Yeo Lab |
Caption: Western blot following shRNA against IGF2BP3 in K562 and HepG2 whole cell lysate using IGF2BP3 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different shRNAs against IGF2BP3. Lanes follow the same pattern, but in HepG2. IGF2BP3 protein appears as the green band, Tubulin serves as a control and appears in red. Releated Sample: BGKLV11-19 Status: Released Lab: Graveley Lab |
|---|